Mercaptopurine Suspension
Product Images NDC 0054-4582

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Mercaptopurine (NDC 0054-4582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mercaptopurine 01)

Chemical structure of mercaptopurine monohydrate showing its molecular arrangement including nitrogen, sulfur, and hydrogen atoms.*

FDA Label Image

Figure A (Mercaptopurine 02)

An instructional illustration showing a hand holding a bottle shaking it with an open cap, demonstrated by curved arrows indicating back-and-forth motion to ensure proper mixing of the suspension before use.*

FDA Label Image

Figure B (Mercaptopurine 03)

An instructional illustration showing how to open a child-resistant cap on a medication bottle. One hand is pressing down on the cap while the other hand is turning it counterclockwise to remove it.*

FDA Label Image

Figure C (Mercaptopurine 04)

An instructional illustration showing hands pressing down on a child-resistant cap of a medication bottle, indicating how to open the bottle. The cap is removed and placed beside the bottle.*

FDA Label Image

Figure D (Mercaptopurine 05)

A black-and-white line drawing illustration of an oral syringe labeled with parts: tip, markings, barrel, and plunger. The diagram clearly identifies each part of the syringe used for administering liquid medication.*

FDA Label Image

Figure E (Mercaptopurine 06)

An instructional illustration showing a hand pressing down a syringe plunger inserted into a bottle or vial, with a downward arrow indicating the direction to push. This image likely demonstrates how to extract suspension medication from the container using the syringe.*

FDA Label Image

Figure F (Mercaptopurine 07)

An instructional illustration showing a hand holding a bottle upside down and drawing liquid into a syringe held by the other hand, indicating the process of withdrawing oral suspension medication from the bottle using a syringe.*

FDA Label Image

Mercaptopurine Oral Suspension (Bottle Carton)

Packaging label for Mercaptopurine Oral Suspension 20 mg/mL (2000 mg/100 mL) by Hikma Pharmaceuticals USA Inc. The label includes instructions to shake vigorously before use for at least 30 seconds, storage conditions, inactive ingredients, and a warning for phenylketonurics. It also notes the package contains a 100 mL glass bottle, bottle adapter, and oral dispensing syringes.*

FDA Label Image

Mercaptopurine Oral Suspension (Bottle Label)

Label of Mercaptopurine oral suspension 20 mg/mL (2000 mg/100 mL) in a 100 mL bottle by Hikma Pharmaceuticals USA Inc. The label includes dosing instructions, storage conditions, inactive ingredients, and a barcode. It specifies shaking well before use and discarding the unused portion 8 weeks after first opening.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.